Développement et évaluation de poudres sèches pour inhalation à base d'itraconazole dans le cadre du traitement et de la prévention de l'aspergillose pulmonaire

Développement et évaluation de poudres sèches pour inhalation à base d'itraconazole dans le cadre du traitement et de la prévention de l'aspergillose pulmonaire

Compte tenu de ses aspects multiples, de sa dangerosité potentielle et du taux de<p>survie considérablement bas qui lui est associé dans ses formes les plus graves, l’aspergillose<p>pulmonaire est encore à l’heure actuelle dévastatrice sur le plan clinique. L’approche<p>médicamente...

Full description

Bibliographic Details
Main Author:	Duret, Christophe
Other Authors:	Amighi, Karim
Format:	Doctoral Thesis
Language:	fr
Published:	Universite Libre de Bruxelles 2013
Subjects:	Sciences pharmaceutiques Pulmonary aspergillosis > Treatment Antifungal agents Powders (Pharmacy) Inhalers Aspergillose pulmonaire > Traitement Antifongiques Poudres (Pharmacie) Inhalateurs insufflation dry powder pulmonary aerosol Itraconazole antifungal aspergillosis aspergillus DPI solubility inhalation poorly soluble nanoparticle solid dispersion dissolution
Online Access:	https://dipot.ulb.ac.be/dspace/bitstream/2013/209499/1/efde2ce5-f17c-4d97-9637-b10fc51da3a6.txt https://dipot.ulb.ac.be/dspace/bitstream/2013/209499/2/76cce737-8dad-45d7-9beb-88e74a1332fd.txt http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209499

Similar Items

Développement et évaluation de formulations lipidiques à poudre sèche pour inhalation
by: Sebti, MOHAMED THAMI
Published: (2006)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
by: Shen Nam Cheng, et al.
Published: (2020-11-01)

Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention
by: Ranjot Kaur, et al.
Published: (2021-01-01)

Development of dry powder formulations of proteins for inhalation
by: Depreter, Flore
Published: (2012)

Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
by: Mehdi Hassanpour Aghdam, et al.
Published: (2016-03-01)

Prévention, contrôle et maîtrise du risque d’aspergillose invasive au Groupement Hospitalier Edouard Herriot lors de travaux : apport de la surveillance et de l’alerte environnementale et épidémiologique
by: Loeffert, Sophie
Published: (2017)

Nouvelles stratégies de traitement de l'aspergillose : ciblage d'Aspergillus fumigatus par des anticorps thérapeutiques et ciblage du microenvironnement fongique
by: Chauvin, David
Published: (2018)

Développement et caractérisation physico-chimique d'une nouvelle forme galénique à base d'Amphotéricine B adaptée à la voie orale et pulmonaire
by: Mehenni, Lyes
Published: (2018)

Développement et évaluation de formulations lipidiques à poudre sèche pour inhalation
by: Sebti, Thami
Published: (2006)

Development of Triazole-based Dry Powder Formulations for Inhalation
by: Merlos, Romain
Published: (2019)

Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions
by: Hisham Al-Obaidi, et al.
Published: (2021-07-01)

Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
by: Edit Benke, et al.
Published: (2020-06-01)

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
by: Federico Lavorini
Published: (2019-06-01)

A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians
by: Paige M.K. Larkin, et al.
Published: (2020-07-01)

Apport de la protéomique dans l'amélioration de l'exploration de l'aspergillose pulmonaire invasive à partir d'un modèle murin
by: Desoubeaux, Guillaume
Published: (2013)

Role of itraconazole in the management of aspergillosis in treated patients of pulmonary tuberculosis
by: Gupta P, et al.
Published: (2005-01-01)

Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery
by: Satu Lakio, et al.
Published: (2015-12-01)

Investigation of semipermeable coated tablet and liposomal dry powder inhaler formulation of salbutamol sulfate
by: Huang, Wenhua
Published: (2010)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Allergic Bronchopulmonary Aspergillosis masquerading as recurrent bacterial pneumonia
by: Vu Le Thuong, et al.
Published: (2016-06-01)

Antifungal Activity of Gentamicin B1 Against Systemic Plant Mycoses
by: Gaspar Banfalvi
Published: (2020-05-01)

Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species
by: Abdullah, A., et al.
Published: (2022)

Pediatric Invasive Aspergillosis
by: Rachel L. Wattier, et al.
Published: (2016-06-01)

The Use of a Three-Fluid Atomising Nozzle in the Production of Spray-Dried Theophylline/Salbutamol Sulphate Powders Intended for Pulmonary Delivery
by: Stefano Focaroli, et al.
Published: (2020-11-01)

Errors in inhaler use related to devices and to inhalation technique among patients with chronic obstructive pulmonary disease in primary health care
by: Annika Lindh, et al.
Published: (2019-10-01)

Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications
by: Zhanying Zheng, et al.
Published: (2021-02-01)

Diagnostik der Aspergillose bei Jagdfalken (Falco spp.) unter besonderer Berücksichtigung der Projektionsradiographie und der Serumelektrophorese
by: Vorbrüggen, Susanne
Published: (2013)

Use of antifungal drugs in hematology
by: Marcio Nucci
Published: (2012-01-01)

Dispensing Guideline of Dry Powder Inhaler for Asthmatic and Chronic Obstructive Pulmonary Disease Patients at Out-Patient Dispensing Department
by: Karnchanok Maliphan, et al.
Published: (2012-10-01)

Antifungal Siderophore Conjugates for Theranostic Applications in Invasive Pulmonary Aspergillosis Using Low-Molecular TAFC Scaffolds
by: Joachim Pfister, et al.
Published: (2021-07-01)

Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease
by: Bang C, et al.
Published: (2013-09-01)

A comparative analysis of errors in inhaler technique among COPD versus asthma patients
by: Ocakli B, et al.
Published: (2018-09-01)

CPAnet Registry—An International Chronic Pulmonary Aspergillosis Registry
by: Christian B. Laursen, et al.
Published: (2020-06-01)

INVESTIGATION OF SENSITIVITY TO ANTIFUNGAL AGENTS IN ASPERGILLUS FUNGICAUSING BRONCHIAL PULMONARY IN FECTION IN TUBERCULOSIS PATIENTS
by: A. B. Kulko
Published: (2017-08-01)

Développement et évaluation de formulations pour inhalation à base d'anticancéreux dans le cadre du traitement des tumeurs pulmonaires
by: Wauthoz, Nathalie
Published: (2011)

Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance
by: Darbà J, et al.
Published: (2016-02-01)

Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
by: Iching G. Yu, et al.
Published: (2021-04-01)

Practical, regulatory and clinical considerations for development of inhalation drug products
by: Shuguang Hou, et al.
Published: (2015-12-01)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01)

Knowledge and practice of dry powder inhalation among patients with chronic obstructive pulmonary disease in a regional hospital, Nepal
by: Baral MA
Published: (2018-12-01)

Cannot write session to /tmp/vufind_sessions/sess_ivk1752iuemeaaji7gcocu9hqk